Dr. Przemyslaw Twardowski MD Medical Oncologist

Dr. Przemyslaw Twardowski is a medical oncologist in Duarte, California and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice for 20 years. He is one of 18 doctors at City of Hope's Helford Clinical Research Hospital who specialize in Medical Oncology.

Are you Dr. Przemyslaw Twardowski? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: Genitourinary

Hospital Affiliation

City of Hope's Helford Clinical Research Hospital
Ranked #15 in Cancer

Education & Medical Training

McGaw Medical Center of Northwestern University
Residency, Internal Medicine, 1990 - 1993

McGaw Medical Center of Northwestern University
Fellowship, Hematology, 1993 - 1994

McGaw Medical Center of Northwestern University
Fellowship, Hematology/Oncology, 1994 - 1997

University of Missouri-Columbia School of Medicine
Class of 1990

Certifications & Licensure

American Board of Internal Medicine
Certified 20 years in Internal Medicine

American Board of Internal Medicine
Certified 16 years in Hematology

American Board of Internal Medicine
Certified 16 years in Medical Oncology

CA State Medical License
Active through 2014

Publications & Presentations

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Twardowski, P. W.,Beumer, J. H.,Chen, C. S.,Kraft, A. S.,Chatta, G. S.,Mitsuhashi, M.,Ye, W.,Christner, S. M.,Lilly, M. B.

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
Quinn, D. I.,Tangen, C. M.,Hussain, M.,Lara, P. N.,Goldkorn, A.,Moinpour, C. M.,Garzotto, M. G.,Mack, P. C.,Carducci, M. A.,Monk, J. P.,Twardowski, P. W.,Van Veldhuizen, P. J.,Agarwal, N.,Higano, C. S.,Vogelzang, N. J.,Thompson, I. M.

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies.
Weiss, G. J.,Chao, J.,Neidhart, J. D.,Ramanathan, R. K.,Bassett, D.,Neidhart, J. A.,Choi, C. H.,Chow, W.,Chung, V.,Forman, S. J.,Garmey, E.,Hwang, J.,Kalinoski, D. L.,Koczywas, M.,Longmate, J.,Melton, R. J.,Morgan, R.,Oliver, J.,Peterkin, J. J.,Ryan, J. L.,Schluep, T.,Synold, T. W.,Twardowski, P.,Davis, M. E.,Yen, Y.

See all 41 publications
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.